T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis

Not Recruiting

Trial ID: NCT01078337

Age - N/A-18 Years Condition - Acute Lymphoid leukemia (ALL), Pediatric Cancer Gender - All Accepting Healthy Volunteers - No

Purpose

To determine if MRD (minimal residual disease) can be found in the blood (only) as opposed to bone marrow in children with ALL (acute lymphoblastic leukemia).

Official Title

T-cell MRD Evaluation Using Flow Cytometric Analysis

Stanford Investigator(s)

Gary Dahl

Eligibility


Inclusion Criteria:

   - Children with newly diagnosed T-cell ALL

View More
View Less

Intervention(s):

procedure: Bone marrow aspiration

procedure: peripheral blood sampling

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Nadeem Mukhtar
6504978815

New Trial Alerts

Receive email alerts when trials open to patients.

©2022 Stanford Medicine